SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-028093
Filing Date
2024-07-17
Accepted
2024-07-17 08:00:22
Documents
17
Period of Report
2024-07-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49878
2 ex10-1.htm EX-10.1 98759
3 ex99-1.htm EX-99.1 15857
4 ex10-1_001.jpg GRAPHIC 30686
5 ex99-1_001.jpg GRAPHIC 30178
  Complete submission text file 0001493152-24-028093.txt   451719

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcsa-20240716.xsd EX-101.SCH 3060
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcsa-20240716_lab.xml EX-101.LAB 34240
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcsa-20240716_pre.xml EX-101.PRE 22389
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3702
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 241120978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)